Public Alert No. 030/2026: Alert on the Withdrawal of Levamisole-Containing Medicines as endorsed by the Italian Medicines Agency (AIFA) over serious Neurological risks
The National Agency for Food and Drug Administration and Control received a notification that on 6 April 2026, the Italian Medicines Agency (AIFA) endorsed a safety recommendation to withdraw medicines containing levamisole from the EU market. This recommendation was issued by the European Medicines Agency (EMA) safety committee known as the Pharmacovigilance Risk Assessment Committee […]
Public Alert No. 029/2026 – Recall of Impala Brand Gel Nail Polish Products by Brazilian Health Regulatory Authority(ANVISA)
The National Agency for Food and Drug Administration and Control (NAFDAC) received a notification that the Brazilian Health Regulatory Agency, the Agência Nacional de Vigilância Sanitária (ANVISA), announced a recall of specific Impala brand gel nail polish products manufactured by Laboratório Avamiller de Cosméticos Ltd. The recall was initiated following the identification of the substance […]
Public Alert No. 028/2026- Recall Of Children’s Ibuprofen Oral Suspension in the United States Due To Potential Contamination With Foreign Material
The National Agency for Food and Drug Administration and Control (NAFDAC) received a notification that the United States Food and Drug Administration (USFDA) has announced the recall of approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension, USP (100 mg/5 mL) due to the presence of foreign material in the product. Strides Pharma Inc. initiated the […]
